We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
UK-based medical software developer Brainomix has partnered with French medical imaging company Pixyl, to expand its offering with multiple sclerosis treatment solution. Under the collaboration, Brainomix will distribute
US-based biomedical company Boston Scientific has unveiled positive results from the post-market clinical follow-up (PMCF) study of its ACURATE neo2 aortic valve system. The ACURATE neo2 PMCF study
The Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland, the European Laboratory for Particle Physics (CERN) and THERYQ (ALCEN Group) have signed an agreement for the world-first development of a revolutionary
LumiraDx Healthcare, a next-generation point-of-care diagnostics platform, has rolled out its C-Reactive Protein (CRP) point-of-care antigen test across India. The company said the high-sensitive point-of-care test can be
US-based augmented reality glasses manufacturer Rokid, in partnership with Eyedaptic, a developer of wearable devices for enhanced vision, has unveiled the new EYE5 smart glasses. The new smart
Edenlux (CEO Sy Park) announced that it will provide an artificial intelligence (AI) eye health management report for the users of Otus Plus, its flagship product. The company,
AnchorDx, a China-based developer of cancer early detection solutions, has recruited the first patient in the US clinical study of its UriFind bladder cancer assay. The clinical trial
Germany-based digital health company Temedica has secured €25m in an extended Series B funding round to expand its real-world insights ecosystem. The extended financing round, which brings the
Ferrum Health, a leader in healthcare enterprise AI solutions, announces an agreement with iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, to offer iCAD’s breast
US-based medical equipment manufacturer Lucira Health has secured the US Food and Drug Administration (FDA) emergency use authorisation (EUA) for its Lucira Covid-19 & Flu Test. The Lucira